ARCHIVES

NCI To Require Reports On Adverse Drug Reactions From Trials

This article is from The Cancer Letter archive.

Vol. 20 No. 23 | June 10, 1994

Download PDF Visit The Full Archive

Related Articles

FDA’s Handling Of UFT Raises Questions About Agency’s Isolation, Grasp Of Science.

July 21, 2000

Specific Pathology Pattern Can Predict Recurrence

August 30, 2013

DCT Board Approves Concept For BRMP Master Agreement

June 26, 1987

Also Anna Barker gets new, longer title at NCI; Mark Clanton named deputy director for care, delivery.

February 13, 2004

ASCO Survey Finds Docs’ Quality Time With Patients Down, Due To Paperwork.

June 22, 2001

Dose Adjustments Of Other Drugs Questioned; Underdosing Or Overdosing?

October 15, 2010